Healthcare and Life Science
Rational VHH Humanisation: Keeping the binder you started with
Isogenica's latest case study shows how a structure-guided, iterative approach to VHH humanisation can push nanobodies to 80%+ human-likeness while retaining antigen binding, expression and stability, avoiding the common pitfall of trading away a good binder's properties in pursuit of s...
Nuclera appoints Carl Raimond as Chief Executive Officer
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business OfficerCambr...
ROAR Events Agency and Holiday Inn Cambridge launch a summer party partnership for 2027
Cambridge, UK – September 2026 – ROAR Events Agency has announced a new partnership with Holiday Inn Cambridge to deliver a programme of large-scale corporate summer parties and outdoor events throughout May to September 2027. ...
CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO
Tony Quested writes: CEO Will West winged in from New York as his company CellCentric won the 36th annual Business Weekly Awards' coveted Business of the Year crown at Queens' College. ...
What does it take to build a world-class company in the UK?
The UK has no shortage of great ideas. The harder question is whether we have the capital, people and appetite for risk to turn more of them into world-class companies that grow and stay here. ...
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK fundingFounding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMostInitially focused on cancer and...
Acquisition of Corazon Health by HCML
Corazon Health announced today that it has been acquired by HCML, a leading provider of health, rehabilitation, case management, and treatment services. This acquisition enhances Corazon’s operational capacity, scaling its ability to support an expanded corporate client base across the ...
Your visitor has landed. Now what? Planning international arrivals to Cambridge
Somewhere over the Atlantic right now, a visiting researcher is trying to work out how to get from Heathrow to Cambridge. They have a hotel name, a meeting at nine tomorrow morning, and a phone that may not connect as expected when they land. ...
electronRx to launch purpleDx Pulmonary Disease Smartphone App for remote lung function monitoring
Cambridge, UK, 12 December 2024: electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at ...
Research Roundup: Summer 2026
Welcome to our new research roundup. Each quarter we will highlight new research publications that include the NIHR BioResource and our participants. We have summarised each publication below, including links to the journal and any associated news articles. ...